85 related articles for article (PubMed ID: 10432481)
1. In vivo assessment of aging changes in serotonin function.
Meltzer CC; Reynolds CF
Neuropsychopharmacology; 1999 Aug; 21(2):323-4. PubMed ID: 10432481
[No Abstract] [Full Text] [Related]
2. New halogenated [11C]WAY analogues, [11C]6FPWAY and [11C]6BPWAY--radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkey.
Sandell J; Halldin C; Pike VW; Chou YH; Varnäs K; Hall H; Marchais S; Nowicki B; Wikström HV; Swahn CG; Farde L
Nucl Med Biol; 2001 Feb; 28(2):177-85. PubMed ID: 11295428
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modelling.
Osman S; Lundkvist C; Pike VW; Halldin C; McCarron JA; Swahn CG; Farde L; Ginovart N; Luthra SK; Gunn RN; Bench CJ; Sargent PA; Grasby PM
Nucl Med Biol; 1998 Apr; 25(3):215-23. PubMed ID: 9620626
[TBL] [Abstract][Full Text] [Related]
4. Serotonin 5-HT1A receptor imaging in the human brain with positron-emission tomography: coordination and the standardization and dissemination of methodology.
Halldin C
J Clin Pharmacol; 2001 Jul; 41(S7):95S. PubMed ID: 11452735
[No Abstract] [Full Text] [Related]
5. Serotonin 5-HT1A receptor binding potential declines with age as measured by [11C]WAY-100635 and PET.
Tauscher J; Verhoeff NP; Christensen BK; Hussey D; Meyer JH; Kecojevic A; Javanmard M; Kasper S; Kapur S
Neuropsychopharmacology; 2001 May; 24(5):522-30. PubMed ID: 11282252
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man.
Farde L; Ito H; Swahn CG; Pike VW; Halldin C
J Nucl Med; 1998 Nov; 39(11):1965-71. PubMed ID: 9829590
[TBL] [Abstract][Full Text] [Related]
7. A database of [(11)C]WAY-100635 binding to 5-HT(1A) receptors in normal male volunteers: normative data and relationship to methodological, demographic, physiological, and behavioral variables.
Rabiner EA; Messa C; Sargent PA; Husted-Kjaer K; Montgomery A; Lawrence AD; Bench CJ; Gunn RN; Cowen P; Grasby PM
Neuroimage; 2002 Mar; 15(3):620-32. PubMed ID: 11848705
[TBL] [Abstract][Full Text] [Related]
8. Gender-specific aging effects on the serotonin 1A receptor.
Cidis Meltzer C; Drevets WC; Price JC; Mathis CA; Lopresti B; Greer PJ; Villemagne VL; Holt D; Mason NS; Houck PR; Reynolds CF; DeKosky ST
Brain Res; 2001 Mar; 895(1-2):9-17. PubMed ID: 11259754
[TBL] [Abstract][Full Text] [Related]
9. In vivo binding properties of [carbonyl-11C]WAY-100635: effect of endogenous serotonin.
Maeda J; Suhara T; Ogawa M; Okauchi T; Kawabe K; Zhang MR; Semba J; Suzuki K
Synapse; 2001 May; 40(2):122-9. PubMed ID: 11252023
[TBL] [Abstract][Full Text] [Related]
10. Fluoro analogs of WAY-100635 with varying pharmacokinetics properties.
Lang L; Jagoda E; Schmall B; Sassaman M; Ma Y; Eckelman WC
Nucl Med Biol; 2000 Jul; 27(5):457-62. PubMed ID: 10962250
[TBL] [Abstract][Full Text] [Related]
11. Quantification of [Carbonyl-(11)C]WAY-100635 binding: considerations on the cerebellum.
Oikonen V; Allonen T; Någren K; Kajander J; Hietala J
Nucl Med Biol; 2000 Jul; 27(5):483-6. PubMed ID: 10962255
[TBL] [Abstract][Full Text] [Related]
12. Modeling [18 F]MPPF positron emission tomography kinetics for the determination of 5-hydroxytryptamine(1A) receptor concentration with multiinjection.
Costes N; Merlet I; Zimmer L; Lavenne F; Cinotti L; Delforge J; Luxen A; Pujol JF; Le Bars D
J Cereb Blood Flow Metab; 2002 Jun; 22(6):753-65. PubMed ID: 12045674
[TBL] [Abstract][Full Text] [Related]
13. Localization of 5-HT1A receptors in the living human brain using [carbonyl-11C]WAY-100635: PET with anatomic standardization technique.
Ito H; Halldin C; Farde L
J Nucl Med; 1999 Jan; 40(1):102-9. PubMed ID: 9935065
[TBL] [Abstract][Full Text] [Related]
14. Derivation of [(11)C]WAY-100635 binding parameters with reference tissue models: effect of violations of model assumptions.
Slifstein M; Parsey RV; Laruelle M
Nucl Med Biol; 2000 Jul; 27(5):487-92. PubMed ID: 10962256
[TBL] [Abstract][Full Text] [Related]
15. Workshop on 5-HT1A receptor imaging--modelling of [carbonyl-11C]WAY-100635 in the human brain. 6 May 1999, PET Centre, San Raffaele, Milan, Italy.
Eur J Nucl Med; 1999 Aug; 26(8):948-50. PubMed ID: 10515717
[No Abstract] [Full Text] [Related]
16. Serotonin 5-HT1A receptor imaging in the human brain with PET. Co-ordination of the standardisation and dissemination of methodology. Workshop on [carbonyl-11C]WAY-100635 radiochemistry and metabolite analysis 30-31 March 1999. MRC Cyclotron Unit, London, UK.
Pike VW
Eur J Nucl Med; 1999 Aug; 26(8):946-8. PubMed ID: 10515716
[No Abstract] [Full Text] [Related]
17. Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET.
Gunn RN; Sargent PA; Bench CJ; Rabiner EA; Osman S; Pike VW; Hume SP; Grasby PM; Lammertsma AA
Neuroimage; 1998 Nov; 8(4):426-40. PubMed ID: 9811559
[TBL] [Abstract][Full Text] [Related]
18. Radioligands for brain 5-HT2 receptor imaging in vivo: why do we need them?
Busatto GF
Eur J Nucl Med; 1996 Aug; 23(8):867-70. PubMed ID: 8753673
[No Abstract] [Full Text] [Related]
19. Neuroendocrine evidence for age-related decline in central serotonergic function.
Lerer B; Gelfin Y; Shapira B
Neuropsychopharmacology; 1999 Aug; 21(2):321-2. PubMed ID: 10432480
[No Abstract] [Full Text] [Related]
20. Imaging the 5-HT(1A) receptors with PET: WAY-100635 and analogues.
Houle S; DaSilva JN; Wilson AA
Nucl Med Biol; 2000 Jul; 27(5):463-6. PubMed ID: 10962251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
